Attenuation of cyclic nucleotide-mediated smooth muscle relaxation in blacks as a cause of racial differences in vasodilator function

Circulation

Volumn 99, Issue 1, 1999, Pages 90-95

  Cardillo, Carmine ^a   Kilcoyne, Crescence M ^a   Cannon III, Richard O ^a   Panza, Julio A ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Nitric oxide; Nucleotides, cyclic; Race; Receptors, adrenergic, beta; Vasodilation

Indexed keywords

BETA ADRENERGIC RECEPTOR; CYCLIC NUCLEOTIDE; ISOPRENALINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ACETYLCHOLINE RELEASE; ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; DRUG EFFECT; ENVIRONMENTAL FACTOR; FEMALE; GENETIC RISK; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PATHOPHYSIOLOGY; PLETHYSMOGRAPHY; PRIORITY JOURNAL; RACE DIFFERENCE; SMOOTH MUSCLE RELAXATION; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 0033547736     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.1.90     Document Type: Article

References (39)

1. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1981-1991. Hypertension. 1995;25:305-313.
2. Cornoni-Huntley J, LaCroix AZ, Havlik RJ. Race and sex differences in the impact of hypertension in the United States. Arch Intern Med. 1989; 149:78-88.
3. National Center for Health Statistics. Vital Statistics of the United States, 1977: Mortality, Vol 2. Hyattsville, Md: US Department of Health, Education and Welfare; 1977.
4. Gillum RF. Pathophysiology of hypertension in blacks and whites. Hypertension. 1979;1:468-475.
5. Falkner B. Differences in blacks and whites with essential hypertension: biochemistry and endocrine. Hypertension. 1990;15:681-686.
6. Kaplan NM. Ethnic aspects of hypertension. Lancet. 1994;344: 450-452.
7. Murphy JK, Alpert BS, Moes DM, Somes GW. Race and cardiovascular reactivity: a neglected relationship. Hypertension. 1986;8: 1075-1083.
8. Anderson NB, Lane JD, Muranaka M, Williams RB Jr, Houseworth SJ. Racial differences in blood pressure and forearm vascular responses to the cold face stimulus. Psychosom Med. 1988;50:57-63.
9. Anderson NB, Myers HF, Pickering T, Jackson JS. Hypertension in blacks: psychosocial and biological perspectives. J Hypertens. 1989;7: 161-172.
10. McAdoo WG, Weinberger MH, Miller JZ, Finenberg NS, Grim CE. Race and gender influence hemodynamic responses to psychological and physical stimuli. J Hypertens. 1990;8:961-967.
11. Lang CC, Stein CM, Brown RM, Deegan R, Nelson R, He HB, Wood M, Wood AJJ. Attenuation of isoproterenol-mediated vasodilatation in blacks. N Engl J Med. 1995;333:155-160.
12. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 1989;2: 997-1000.
13. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. Circulation. 1993;87: 1468-1474.
14. Cardillo C, Kilcoyne CM, Quyyumi AA, Cannon III RO, Panza JA. Decreased vasodilator response to isoproterenol during nitric oxide inhibition in humans. Hypertension. 1997;30:918-921.
15. Dawes M, Chowienczyk PJ, Ritter JM. Effects of inhibition of the L-argìnine/nitric oxide pathway on vasodilation caused by β-adrenergic agonists in human forearm. Circulation. 1997;95:2293-2297.
16. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27.
17. Linder L, Kiowski W, Buhler FR, Luscher TF. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Circulation. 1990;81:1762-1767.
18. Hirooka Y, Imaizumi T, Masaki H, Ando S, Harada S, Momohara M, Takeshida A. Captopril improves impaired endothelium-dependent vasodilation in hypertensive patients. Hypertension. 1992;20:175-180.
19. G-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens. 1992; 10:1025-1031.
20. Taddei S, Virdis A, Mattei P, Ghiadoni L, Sudano I, Salvetti A. Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation. 1996;94:1298-1303.
21. Stein CM, Lang CC, Nelson R, Brown M, Wood AJ. Vasodilation in black Americans: attenuated nitric oxide-mediated responses. Clin Pharmacol Ther. 1997;62:436-443.
22. Whitney RJ. Measurement of changes in human limb volume by means of a mercury-in-rubber strain gauge. J Physiol (Lond). 1948;109:5P-6P.
23. Kerslake DM. The effect of application of an arterial occlusion cuff to the wrist on the blood flow in the human forearm. J Physiol (Lond). 1949; 108:451-457.
24. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle to acetylcholine. Nature. 1980;288: 373-376.
25. Bohme E, Graf H, Schultz G. Effects of sodium nitroprusside and other smooth muscle relaxant on cyclic-GMP formation in smooth muscle and platelets. Adv Cycl Nucl Res. 1978;9:131-143.
26. Carlsson I, Sollevi A, Wennmalm A. The role of myogenic relaxation, adenosine and prostaglandins in human reactive hyperemia. J Physiol (Lond). 1987;389:147-161.
27. Tagawa T, Imaizumi T, Endo T, Shiramoto M, Harasawa Y, Takeshita A. Role of nitric oxide in reactive hyperemia in human forearm vessels. Circulation. 1994;90:2285-2290.
28. Moncada S, Palmer RM, Higgs EA. Nitric oxide; physiology, pathophysiology and pharmacology. Physiol Rev. 1991;43:109-142.
29. Bassett DR Jr, Duey WJ, Walker AJ, Howley ET, Bond V. Racial differences in maximal vasodilator capacity of forearm resistance vessels in normotensive young adults. Am J Hypertens. 1992;5: 781-786.
30. Hinderliter AL, Sager AR, Sherwood A, Light KC, Girdler SS, Willis PW IV. Ethnic differences in forearm vasodilator capacity. Am J Cardiol. 1996;78:208-211.
31. Folkow B. Physiological aspects of primary hypertension. Physiol Rev. 1982;62:347-504.
32. Insel PA. Adrenergic receptors. Evolving concepts and clinical implications. N Engl J Med. 1996;334:580-585.
33. Rembold CM. Regulation of contraction and relaxation in arterial smooth muscle. Hypertension. 1992;20:129-137.
34. Somlyo AP, Somlyo AV. Signal transduction and regulation in smooth muscle. Nature. 1994;372:231-236.
35. Calhoun DA, Oparil S. Racial differences in the pathogenesis of hypertension. Am J Med Sci. 1995;310(suppl 1):S86-S90.
36. Weinberger MH. Hypertension in African Americans, the role of sodium chloride and extracellular fluid volume. Semin Nephrol. 1996;16:110-116.
37. Aviv A. Cellular calcium and sodium regulation, salt-sensitivity and essential hypertension in African Americans. Ethn Health. 1996;1: 275-281.
38. Somlyo AP. Romantic interludes raise blood pressure. Nature. 1997;389: 908-911.
39. Lenfant C. Report of the NHLBI Working Group on research in coronary heart disease in blacks. Circulation. 1994;90:1613-1623.